4568.T
DAIICHI SANKYO COMPANY,LIMITED
プライム · 医薬品 · 医薬品 · JP
JPY 2,617.50
+1.45%Next report
Analyst consensus
- Next report date
- Oct 30, 2026
- EPS estimate
- JPY 39
- Revenue estimate
- JPY 565.8B
Latest reported
- Last report date
- Oct 30, 2026
- EPS actual
- —
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 30, 2026 | JPY 39 | JPY 46 | Beat 17.06% | JPY 593.4B |
| Jul 31, 2026 | JPY 41 | JPY 38 | Miss -7.32% | JPY 568.1B |
| May 11, 2026 | JPY 52 | JPY 23 | Miss -55.97% | JPY 589.6B |
| Jan 29, 2026 | JPY 39 | JPY 46 | Beat 19.53% | JPY 558.1B |
| Oct 29, 2025 | JPY 47 | JPY 26 | Miss -45.30% | JPY 500.8B |
| Apr 23, 2025 | JPY 19 | JPY 44 | Beat 137.97% | JPY 518.7B |
| Jan 29, 2025 | JPY 33 | JPY 32 | Miss -0.62% | JPY 484.8B |
| Oct 31, 2024 | JPY 26 | JPY 32 | Beat 22.08% | JPY 446.6B |
| Jul 31, 2024 | JPY 23 | JPY 45 | Beat 91.42% | JPY 436.2B |
| Apr 25, 2024 | JPY 7.56 | JPY 19 | Beat 156.35% | JPY 428.4B |
| Jan 31, 2024 | JPY 17 | JPY 35 | Beat 104.30% | JPY 446.9B |
| Oct 31, 2023 | JPY 20 | JPY 21 | Beat 3.01% | JPY 375.5B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jan 29, 2027